Gweneth Levy

Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up)

Jonathan I. Silverberg, Christopher G. Bunick, Hwanhee Hong et al. · British Journal of Dermatology · 2024 · 50 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study

Séverine Vermeire, Silvio Danese, Wen Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 49 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports

Uma Mahadevan, Gweneth Levy, Lianne S. Gensler et al. · Drug Safety · 2024 · 35 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +17

Efficacy and safety of upadacitinib for 16‐week extended induction and 52‐week maintenance therapy in patients with moderately to severely active ulcerative colitis

Remo Panaccione, Silvio Danese, Wen Zhou et al. · Alimentary Pharmacology & Therapeutics · 2023 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease

Gerd R Burmester, Atul Deodhar, Alan D. Irvine et al. · Advances in Therapy · 2025 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17